scispace - formally typeset
D

Dawn Waterworth

Researcher at GlaxoSmithKline

Publications -  19
Citations -  2524

Dawn Waterworth is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Polycystic ovary & Genome-wide association study. The author has an hindex of 14, co-authored 19 publications receiving 2294 citations. Previous affiliations of Dawn Waterworth include Imperial College London.

Papers
More filters
Journal ArticleDOI

Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17

TL;DR: Variation in the A2 allele of the CYP17 gene is a significant factor modifying the expression of PCO/MPB in families where it has been demonstrated to segregate as a single gene disorder, but it is excluded as the primary genetic defect.
Journal ArticleDOI

Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome

TL;DR: Mapping of susceptibility to PCOS to the INS VNTR implies that PCOS is due, in part, to an inherited alteration in insulin production, which suggests a mechanistic link between type 2 diabetes and PCOS, which is a risk factor for diabetes later in life.
Journal ArticleDOI

Association of the Steroid Synthesis Gene Cyp11a with Polycystic Ovary Syndrome and Hyperandrogenism

TL;DR: The data demonstrate that variation in CYP11a may play an important role in the aetiology of hyperandrogenaemia which is a common characteristic of polycystic ovary syndrome.
Journal ArticleDOI

The genetic basis of polycystic ovary syndrome.

TL;DR: The results of recent studies support the concept of an oligogenic disorder in which genes affecting metabolic pathways in glucose homeostasis and steroid biosynthesis are both involved and support the proposed interaction of a small number of key genes with environmental, particularly nutritional, factors.